Christopher P Kiritsy - Net Worth and Insider Trading
Christopher P Kiritsy Net Worth
The estimated net worth of Christopher P Kiritsy is at least $4,268 dollars as of 2024-11-05. Christopher P Kiritsy is the Director of Pieris Pharmaceuticals Inc and owns about 250 shares of Pieris Pharmaceuticals Inc (PIRS) stock worth over $4,268. Details can be seen in Christopher P Kiritsy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher P Kiritsy has not made any transactions after 2023-05-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher P Kiritsy
Christopher P Kiritsy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher P Kiritsy owns 2 companies in total, including Pieris Pharmaceuticals Inc (PIRS) , and HTG Molecular Diagnostics Inc (HTGMQ) .
Click here to see the complete history of Christopher P Kiritsy’s form 4 insider trades.
Insider Ownership Summary of Christopher P Kiritsy
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PIRS | Pieris Pharmaceuticals Inc | 2023-05-25 | director |
| HTGMQ | HTG Molecular Diagnostics Inc | 2022-01-27 | director |
Christopher P Kiritsy Latest Holdings Summary
Christopher P Kiritsy currently owns a total of 1 stock. Christopher P Kiritsy owns 250 shares of Pieris Pharmaceuticals Inc (PIRS) as of May 25, 2023, with a value of $4,268.
Latest Holdings of Christopher P Kiritsy
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PIRS | Pieris Pharmaceuticals Inc | 2023-05-25 | 250 | 17.07 | 4,268 |
Holding Weightings of Christopher P Kiritsy
Christopher P Kiritsy Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher P Kiritsy has made a total of 1 transactions in Pieris Pharmaceuticals Inc (PIRS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Pieris Pharmaceuticals Inc is the acquisition of 125 shares on May 25, 2023, which cost Christopher P Kiritsy around $8,500.
Insider Trading History of Christopher P Kiritsy
- 1
Christopher P Kiritsy Trading Performance
GuruFocus tracks the stock performance after each of Christopher P Kiritsy's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher P Kiritsy is -50.68%. GuruFocus also compares Christopher P Kiritsy's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher P Kiritsy within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher P Kiritsy's insider trading performs compared to the benchmark.
Performance of Christopher P Kiritsy
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -34.34 | | | | | |
| Relative Return to S&P 500(%) | -34.34 | | | | | |
Christopher P Kiritsy Ownership Network
Ownership Network List of Christopher P Kiritsy
Ownership Network Relation of Christopher P Kiritsy
Christopher P Kiritsy Owned Company Details
What does Pieris Pharmaceuticals Inc do?
Who are the key executives at Pieris Pharmaceuticals Inc?
Christopher P Kiritsy is the director of Pieris Pharmaceuticals Inc. Other key executives at Pieris Pharmaceuticals Inc include 10 percent owner Bvf Gp Holdings Llc , other: See Explanation of Responses Bvf Ii Gp Llc , and 10 percent owner Bvf I Gp Llc .
Pieris Pharmaceuticals Inc (PIRS) Insider Trades Summary
Over the past 18 months, Christopher P Kiritsy made 1 insider transaction in Pieris Pharmaceuticals Inc (PIRS) with a net purchase of 10,000. Other recent insider transactions involving Pieris Pharmaceuticals Inc (PIRS) include a net purchase of 6,000 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of Pieris Pharmaceuticals Inc (PIRS) in total and bought 6,000 shares, with a net purchase of 6,000 shares. During the past 18 months, 0 shares of Pieris Pharmaceuticals Inc (PIRS) were sold and 6,125 shares were bought by its insiders, resulting in a net purchase of 6,125 shares.
Pieris Pharmaceuticals Inc (PIRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pieris Pharmaceuticals Inc Insider Transactions
Christopher P Kiritsy Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher P Kiritsy. Currently GuruFocus does not have mailing address information for Christopher P Kiritsy.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
